rs1054190
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003889.4(NR1I2):c.*659C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.116 in 988,214 control chromosomes in the GnomAD database, including 7,156 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.090 ( 757 hom., cov: 32)
Exomes 𝑓: 0.12 ( 6399 hom. )
Consequence
NR1I2
NM_003889.4 3_prime_UTR
NM_003889.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.08
Publications
41 publications found
Genes affected
NR1I2 (HGNC:7968): (nuclear receptor subfamily 1 group I member 2) This gene product belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain. The encoded protein is a transcriptional regulator of the cytochrome P450 gene CYP3A4, binding to the response element of the CYP3A4 promoter as a heterodimer with the 9-cis retinoic acid receptor RXR. It is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin. Several alternatively spliced transcripts encoding different isoforms, some of which use non-AUG (CUG) translation initiation codon, have been described for this gene. Additional transcript variants exist, however, they have not been fully characterized. [provided by RefSeq, Jul 2008]
NR1I2 Gene-Disease associations (from GenCC):
- pediatric lymphomaInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.119 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NR1I2 | NM_003889.4 | c.*659C>T | 3_prime_UTR_variant | Exon 9 of 9 | ENST00000393716.8 | NP_003880.3 | ||
| NR1I2 | NM_022002.3 | c.*659C>T | 3_prime_UTR_variant | Exon 9 of 9 | NP_071285.1 | |||
| NR1I2 | NM_033013.3 | c.*659C>T | 3_prime_UTR_variant | Exon 9 of 9 | NP_148934.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NR1I2 | ENST00000393716.8 | c.*659C>T | 3_prime_UTR_variant | Exon 9 of 9 | 1 | NM_003889.4 | ENSP00000377319.3 | |||
| NR1I2 | ENST00000337940.4 | c.*659C>T | 3_prime_UTR_variant | Exon 9 of 9 | 1 | ENSP00000336528.4 | ||||
| NR1I2 | ENST00000466380.6 | c.*659C>T | 3_prime_UTR_variant | Exon 9 of 9 | 1 | ENSP00000420297.2 | ||||
| NR1I2 | ENST00000493757.1 | n.2096C>T | non_coding_transcript_exon_variant | Exon 6 of 6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0901 AC: 13687AN: 151974Hom.: 758 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
13687
AN:
151974
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.121 AC: 101184AN: 836122Hom.: 6399 Cov.: 23 AF XY: 0.122 AC XY: 46964AN XY: 386282 show subpopulations
GnomAD4 exome
AF:
AC:
101184
AN:
836122
Hom.:
Cov.:
23
AF XY:
AC XY:
46964
AN XY:
386282
show subpopulations
African (AFR)
AF:
AC:
836
AN:
15794
American (AMR)
AF:
AC:
141
AN:
2068
Ashkenazi Jewish (ASJ)
AF:
AC:
757
AN:
5164
East Asian (EAS)
AF:
AC:
4
AN:
3784
South Asian (SAS)
AF:
AC:
743
AN:
16742
European-Finnish (FIN)
AF:
AC:
18
AN:
282
Middle Eastern (MID)
AF:
AC:
176
AN:
1620
European-Non Finnish (NFE)
AF:
AC:
95633
AN:
763268
Other (OTH)
AF:
AC:
2876
AN:
27400
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
4341
8683
13024
17366
21707
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4674
9348
14022
18696
23370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0900 AC: 13685AN: 152092Hom.: 757 Cov.: 32 AF XY: 0.0866 AC XY: 6441AN XY: 74354 show subpopulations
GnomAD4 genome
AF:
AC:
13685
AN:
152092
Hom.:
Cov.:
32
AF XY:
AC XY:
6441
AN XY:
74354
show subpopulations
African (AFR)
AF:
AC:
2279
AN:
41478
American (AMR)
AF:
AC:
1525
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
472
AN:
3468
East Asian (EAS)
AF:
AC:
5
AN:
5176
South Asian (SAS)
AF:
AC:
189
AN:
4810
European-Finnish (FIN)
AF:
AC:
554
AN:
10558
Middle Eastern (MID)
AF:
AC:
35
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8228
AN:
68006
Other (OTH)
AF:
AC:
238
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
633
1266
1899
2532
3165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
152
304
456
608
760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
82
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.